encorafenib,Binimetinib,Cetuximab
pfizer,ono pharmacueticals,pierre fabre,eli lilly
[]
 i would still start with folfox.
Head, Oncology Division, Tel Aviv Medical Center; Head, Medical School, Tel Aviv University; Head, Israeli National Council for Malignant Diseases